Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1/2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 76Neoplasms 16Prostatic Neoplasms, Castration-Resistant 14Neoplasm Metastasis 9Breast Neoplasms 9Metastatic Castration Resistant Prostate Cancer 8Prostate Cancer Metastatic 5Metastatic Castration-Resistant Prostate Cancer 5Colorectal Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Carcinoma, Non-Small-Cell Lung 4Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 3Metastatic Castration-resistant Prostate Cancer 3Melanoma 3Bulbo-Spinal Atrophy, X-Linked 3mCRPC 2Recurrence 2Pancreatic Neoplasms 2Non-metastatic Castration-resistant Prostate Cancer 2Metastatic Hormone-sensitive Prostate Cancer 2Metastatic Hormone Sensitive Prostate Cancer 2Metastatic Castrate-Resistant Prostate Cancer 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Bites and Stings 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumours 1Seizures 1

Interventions

enzalutamide 3abiraterone 2ostarine 1exemestane 1darolutamide 1Prednisolone 1Docetaxel 1AZD5305 1AZD3514 15'-ACCaagtttcttcAGC-3' 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Bulbo-Spinal Atrophy, X-Linked × enzalutamide × Clear all
NCT03437941 2026-05-15

Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

Corcept Therapeutics

Phase 1/2 Terminated
39 enrolled 43 charts
Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT06764485 2026-05-06

rechARge

Celgene

Phase 3 Recruiting
960 enrolled
Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT02294461 2025-10-24

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

Astellas Pharma Inc

Phase 3 Completed
395 enrolled 25 charts
Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡